T 2226/21 (Optimized cell culture/REGENERON) of 17.09.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T222621.20240917
- Date of decision
- 17 September 2024
- Case number
- T 2226/21
- Petition for review of
- -
- Application number
- 14851841.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Metabolically optimized cell culture
- Applicant name
- Regeneron Pharmaceuticals, Inc.
- Opponent name
- Neuefeind, Regina
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.